NorthWest Biotherapeutics Inc (NWBO)

[MasterKit]

From the 10k:

Revenue Recognition

The Company recognizes revenue in accordance with the terms stipulated under the patient service contract. In various situations, the Company receives certain payments for DCVax®-L for patient treatment. These payments are assessed and recognized in accordance with ASC 606 in the period when the performance obligation has been met.

Not sure where it shows up in the balance sheets, but not sure how else they could realize revenues in "research and other".